Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vratislav Strnad

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
The Lancet. Oncology|January 18, 2017
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trialCsaba Polgár, Oliver J Ott, Guido Hildebrandt, et al.
The Lancet. Oncology|April 27, 2018
Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trialRebekka Schäfer, Vratislav Strnad, Csaba Polgár, et al.
Critical Reviews in Oncology/Hematology|June 8, 2021
The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic reviewHannah M Dahn, Liesbeth J Boersma, Dirk de Ruysscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 29, 2025
ESTRO recommendations on preoperative radiation therapy in breast cancer: current and future perspectives - Endorsed by ASTROAlice Zamagni, Angel Montero Luis, Ingvil Mjaaland, et al.
The Lancet. Oncology|December 15, 2024
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trialIcro Meattini, Maria Carmen De Santis, Luca Visani, et al.
Lancet (London, England)|October 24, 2015
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trialVratislav Strnad, Oliver J Ott, Guido Hildebrandt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 26, 2021
A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancerOrit Kaidar-Person, Hannah M Dahn, Alan M Nichol, et al.
Brachytherapy|July 3, 2025
Joint ABS/GEC-ESTRO Consensus Statement on the objectives of training in brachytherapy for physiciansMira Keyes, Alina Emiliana Sturdza, Juanita Crook, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 17, 2016
GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient complianceOliver J Ott, Vratislav Strnad, Guido Hildebrandt, et al.
Cancer Discovery|February 22, 2022
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast CancerBorja Ruiz-Fernández de Córdoba, Haritz Moreno, Karmele Valencia, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
The Lancet. Oncology|January 18, 2017
Late side-effects and cosmetic results of accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: 5-year results of a randomised, controlled, phase 3 trialCsaba Polgár, Oliver J Ott, Guido Hildebrandt, et al.
The Lancet. Oncology|April 27, 2018
Quality-of-life results for accelerated partial breast irradiation with interstitial brachytherapy versus whole-breast irradiation in early breast cancer after breast-conserving surgery (GEC-ESTRO): 5-year results of a randomised, phase 3 trialRebekka Schäfer, Vratislav Strnad, Csaba Polgár, et al.
Critical Reviews in Oncology/Hematology|June 8, 2021
The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic reviewHannah M Dahn, Liesbeth J Boersma, Dirk de Ruysscher, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 29, 2025
ESTRO recommendations on preoperative radiation therapy in breast cancer: current and future perspectives - Endorsed by ASTROAlice Zamagni, Angel Montero Luis, Ingvil Mjaaland, et al.
The Lancet. Oncology|December 15, 2024
Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trialIcro Meattini, Maria Carmen De Santis, Luca Visani, et al.
Lancet (London, England)|October 24, 2015
5-year results of accelerated partial breast irradiation using sole interstitial multicatheter brachytherapy versus whole-breast irradiation with boost after breast-conserving surgery for low-risk invasive and in-situ carcinoma of the female breast: a randomised, phase 3, non-inferiority trialVratislav Strnad, Oliver J Ott, Guido Hildebrandt, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 26, 2021
A Delphi study and International Consensus Recommendations: The use of bolus in the setting of postmastectomy radiation therapy for early breast cancerOrit Kaidar-Person, Hannah M Dahn, Alan M Nichol, et al.
Brachytherapy|July 3, 2025
Joint ABS/GEC-ESTRO Consensus Statement on the objectives of training in brachytherapy for physiciansMira Keyes, Alina Emiliana Sturdza, Juanita Crook, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 17, 2016
GEC-ESTRO multicenter phase 3-trial: Accelerated partial breast irradiation with interstitial multicatheter brachytherapy versus external beam whole breast irradiation: Early toxicity and patient complianceOliver J Ott, Vratislav Strnad, Guido Hildebrandt, et al.
Cancer Discovery|February 22, 2022
Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast CancerBorja Ruiz-Fernández de Córdoba, Haritz Moreno, Karmele Valencia, et al.
Pageof 16